Clarithromycin plus linezolid as a sequential therapy for implantable-cardioverter-defibrillator infection caused by coagulase-negative staphylococci

Rev Esp Quimioter. 2016 Apr;29(2):107-8. Epub 2016 Feb 16.

Authors

Emilio Guirao-Arrabal¹, Laura León-Ruíz, María José Pérez-Sola, Pedro Luís Carrillo-Alascio

Affiliation

¹ Emilio Guirao-Arrabal, Unidad de Gestión Clínica de Medicina Interna. Hospital La Inmaculada. Avda. Ana Parra, s/n. C.P.: 04600. Huércal-Overa, Almería, Spain. emilio.guirao@gmail.com.

PMID: 26888341

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Anti-Bacterial Agents / therapeutic use*
Clarithromycin / therapeutic use*
Defibrillators, Implantable / adverse effects*
Echocardiography
Humans
Linezolid / therapeutic use*
Male
Myocardial Ischemia / complications
Myocardial Ischemia / therapy
Prosthesis-Related Infections / diagnostic imaging
Prosthesis-Related Infections / drug therapy*
Prosthesis-Related Infections / microbiology
Staphylococcal Infections / drug therapy*
Staphylococcal Infections / microbiology
Treatment Outcome

Substances

Anti-Bacterial Agents
Clarithromycin
Linezolid